Skip to main content

Table 1 Demographic data at baseline

From: Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice

 

Early stage

Middle stage

Late stage

Overall

Age (years)

74.1 (7.91)

76.3 (7.12)

78.3 (6.07)

75.7 (7.4)

Gender, female

84 (52.2%)

100 (57.1%)

41 (67.2%)

225 (56.7%)

White

161 (100.0%)

175 (100.0%)

61 (100.0%)

397 (100%)

Weight (kg)

74.0 (13.7)

72.0 (15.1)

67.6 (11.5)

72.1 (14.1)

Height (cm)

167.0 (8.9)

165.1 (9.1)

164.0 (8.1)

165.7 (8.89)

MMSE score

23.3 (4.2)

18.6 (5.2)

12.5 (5.5)

19.6 (6.1)

ADAS-cog score

16.3 (6.4)

23.4 (8.4)

-

20.0 (8.3)

SIB scorea

-

79.1 (11.3)

62.6 (20.3)

74.7 (16.0)

DAD score

33.3 (6.8)

24.7 (9.4)

13.8 (8.3)

26.4 (10.6)

NPI score

9.7 (9.6)

14.1 (11.7)

22.2 (14.4)

13.9 (12.3)

  1. Data presented as mean (standard deviation) or number (%) of patients (full analysis set). ADAS-cog, Alzheimer's Disease Assessment Scale - cognitive subscale; DAD, Disability Assessment for Dementia; MMSE, Mini-Mental State Estimation; NPI, Neuropsychiatric Inventory; SIB, Severe Impairment Battery.aQuestions 1, 39, and 40 were omitted in this study.